Scholarlink

<p>We encountered two affected male patients born to non-consanguineous parents, who presented with prenatal-onset severe growth impairment, primary microcephaly, developmental delay, adrenal insufficiency, congenital glaucoma, delayed bone aging, craniosynostosis, congenital tracheal stenosis, and primary hypogonadism. By exome sequencing, we identified compound heterozygous <i>TEDC1</i> variants (NM_001134877.1 c.[104-5C&gt;G];[787delG] p.[?];[(Ala263LeufsTer29)] in both affected siblings. We confirmed that the splice site variant, c.104-5C&gt;G, leads to no TEDC1 protein production via nonsense-mediated mRNA decay. The frameshift variant located in the last coding exon, c.787delG, produces a C-terminally truncated protein, which impairs the binding with TEDC2. Thus, both variants are thought to be loss-of-function. TEDC1 and TEDC2 are both required for centriole stability and cell proliferation. Our in vitro experiments using patient-derived cells revealed cell cycle abnormality. Our in vivo study using <i>tedc1</i><sup><i>−/−</i></sup> zebrafish generated by CRISPR/Cas9 successfully recapitulated the growth impairment and cranial bone dysplasia as seen in our patients. The <i>tedc1</i><sup><i>−</i>/<i>−</i></sup> mutant zebrafish were sterile and did not have developed gonads. Furthermore, we showed that biallelic <i>TEDC1</i> deletion causes cilia abnormalities through defective acetylated tubulins.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Biallelic TEDC1 variants cause a new syndrome with severe growth impairment and endocrine complications

  • 期刊论文

  • 发表日期：

    2025年2月20日

查看全文
  • Noriko Miyake,
  • Kentaro Shiga,
  • Yuya Hasegawa,
  • Chisato Iwabuchi,
  • Kohei Shiroshita,
  • Hiroshi Kobayashi,
  • Keiyo Takubo,
  • Fabien Velilla,
  • Akiteru Maeno,
  • Toshihiro Kawasaki,
  • Yukiko Imai,
  • Noriyoshi Sakai,
  • Tomonori Hirose,
  • Atsushi Fujita,
  • Hidehisa Takahashi,
  • Nobuhiko Okamoto,
  • Mikako Enokizono,
  • Shiho Iwasaki,
  • Shuichi Ito,
  • Naomichi Matsumoto

摘要

We encountered two affected male patients born to non-consanguineous parents, who presented with prenatal-onset severe growth impairment, primary microcephaly, developmental delay, adrenal insufficiency, congenital glaucoma, delayed bone aging, craniosynostosis, congenital tracheal stenosis, and primary hypogonadism. By exome sequencing, we identified compound heterozygous TEDC1 variants (NM_001134877.1 c.[104-5C>G];[787delG] p.[?];[(Ala263LeufsTer29)] in both affected siblings. We confirmed that the splice site variant, c.104-5C>G, leads to no TEDC1 protein production via nonsense-mediated mRNA decay. The frameshift variant located in the last coding exon, c.787delG, produces a C-terminally truncated protein, which impairs the binding with TEDC2. Thus, both variants are thought to be loss-of-function. TEDC1 and TEDC2 are both required for centriole stability and cell proliferation. Our in vitro experiments using patient-derived cells revealed cell cycle abnormality. Our in vivo study using tedc1−/− zebrafish generated by CRISPR/Cas9 successfully recapitulated the growth impairment and cranial bone dysplasia as seen in our patients. The tedc1−/− mutant zebrafish were sterile and did not have developed gonads. Furthermore, we showed that biallelic TEDC1 deletion causes cilia abnormalities through defective acetylated tubulins.